Drawing for CHAI

USPTO serial 99841144

CHAI

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
Law office

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with CHAI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

J. Charles Dougherty

J. Charles Dougherty Wright, Lindsey & Jennings LLP200 W. Capitol Ave., Ste. 2300Little Rock, AR 72201United States

Goods and services

ClassDescriptionStatusFirst use
035Business management consulting services in the field of health systems administration; supply chain management consulting services for health commodities; market research services in the fields of pharmaceuticals, diagnostics, vaccines, and medical devices; market analysis services, namely, compiling and analyzing market data relating to pricing, supply, and access to health commodities; procurement services, namely, negotiating prices and contractual terms for health commodities on behalf of third parties; demand aggregation services for health commodity procurement; business administration services for donor-funded global health programs.ACTIVE
036Financial advisory services in the fields of program administration for health financing, health budget analysis, and health insurance design; administration of donor-funded grant programs in the field of global health; lending and financing services, namely, providing credit facilities to facilitate access to pharmaceutical and medical innovations.ACTIVE
041Education and training services, namely, conducting training programs, workshops, seminars, and field-based mentorship for healthcare workers, government health officials, and health system managers; developing and providing training-of-trainers programs in the field of healthcare; developing and distributing educational materials in the fields of public health and health systems management; publishing research reports, policy briefs, market analyses, and technical fact sheets in the fields of global health and health policy.ACTIVE
042Scientific research services in the fields of public health, epidemiology, and health economics; health economics research, namely, modeling the costs and cost-effectiveness of health interventions; geospatial analysis and mapping services in the field of public health; design and development of software platforms for health data management, health facility performance monitoring, and disease campaign management; design and development of data visualization tools and dashboards for health resource planning; technology consulting services in the field of artificial intelligence applications for health systems, including computer-aided diagnostics and clinical decision support; consulting services to developers of artificial intelligence software, namely, providing healthcare and global health domain expertise to inform the design and development of artificial intelligence systems; quality assurance consulting services for pharmaceutical and diagnostic product manufacturers.ACTIVE
044Public health consulting and advisory services for governments, ministries of health, and public health stakeholders; advisory services to governments for the development of regulatory frameworks for artificial intelligence in healthcare; health policy planning and technical advisory services; operational support services for the implementation and management of national health programs; regulatory affairs consulting services for pharmaceutical, diagnostic, and medical device products, namely, advising on regulatory approval pathways; assistive technology needs assessment and screening services for individuals with disabilities; advisory services to governments relating to the development of national assistive technology policies and supply chain frameworks; technical advisory and facilitation services for pharmaceutical technology transfer and generic medicine development.ACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 22, 2026MAFRAPPLICATION FILING RECEIPT MAILED
May 22, 2026NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance